Stay updated on Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T00:40:20.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision: v3.3.3 has been added to the page footer, and HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.
    Difference
    0.1%
    Check dated 2025-12-23T08:43:08.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page history shows a new Revision: v3.3.2 replacing v3.3.1. No substantive changes to the study record or visible content are shown.
    Difference
    0.0%
    Check dated 2025-12-01T16:42:55.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.1 on the page footer.
    Difference
    0.0%
    Check dated 2025-11-24T13:20:02.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The funding/operating status notice was removed from the page; the rest of the record history and trial details remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-17T06:28:42.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The Record History page displays a redesigned layout and updated styling for the version list, while the underlying version data remains unchanged.
    Difference
    0.0%
    Check dated 2025-11-03T01:10:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in PD-1 Refractory Melanoma Clinical Trial page.